29 April 2021 | News
Shycocan is distributed in the UAE for consumers and business customers by Redington Middle East LLC and Ibn Batuta Medicine & Medical Equipment Store LLC
Shycocan, a breakthrough virus-attenuation device invented and manufactured in India, has been launched in the UAE at the International Conference of Pharmacy & Medicine (ICPM) held at Sharjah. This marks the Middle-East debut of the product.
The cylindrical device, Shycocan, is scientifically evidenced to neutralise and help curb the spread of the Coronavirus and Influenza family of viruses in indoor spaces with 99.9 per cent efficacy, enabling schools, colleges, homes and businesses like hospitals, hotels, offices, restaurants, auditoriums, transportation, retail and airports get back to normal and serve the customers in a safe environment.
Remarkably, Shycocan also works on all current and future variants and mutants of these viruses, protecting people's health and saving millions of hours of lost productivity.
Alok Sharma, Chief Executive Officer, Shycocan Corporation, said, "We are delighted to launch the pathbreaking one-of-a-kind virus-attenuation device, the Shycocan, in the UAE in the hope of helping people bring lives and businesses back to normal."
Shycocan is distributed in the UAE for consumers and business customers by Redington Middle East LLC and Ibn Batuta Medicine & Medical Equipment Store LLC.
Dr Rajah Vijay Kumar, Inventor, Shycocan, "When the COVID-19 pandemic struck, the device was sent for testing and regulatory compliances to global laboratories and found to be equally effective against it. It was overwhelming to realise that we had already created the world's first technology to fight the pandemic long before imagining the possibility of such a crisis taking the entire world in its grip."